I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Targeting HER3, a Catalytically Defective Receptor Tyrosine..:
Donatella Romaniello
;
Ilaria Marrocco
;
Nishanth Belugali Nataraj
...
https://www.mdpi.com/2072-6694/12/9/2394. , 2020
Link:
https://doi.org/10.3390/cancers12092394
RT Journal T1
Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:11675062ac2d451c8ec22e88b30f6136&Exemplar=1&LAN=DE A1 Donatella Romaniello A1 Ilaria Marrocco A1 Nishanth Belugali Nataraj A1 Irene Ferrer A1 Diana Drago-Garcia A1 Itay Vaknin A1 Roni Oren A1 Moshit Lindzen A1 Soma Ghosh A1 Matthew Kreitman A1 Jeanette Clarissa Kittel A1 Nadege Gaborit A1 Gretchen Bergado Baez A1 Belinda Sanchez A1 Raya Eilam A1 Eli Pikarsky A1 Luis Paz-Ares A1 Yosef Yarden PB MDPI AG YR 2020 K1 drug resistance K1 EGFR K1 kinase inhibitor K1 lung cancer K1 monoclonal antibody K1 osimertinib K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/12/9/2394 LK http://dx.doi.org/https://doi.org/10.3390/cancers12092394 DO https://doi.org/10.3390/cancers12092394 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)